The Council for Scientific and Industrial Research (CSIR) has developed a low-cost method of producing antiretrovirals (ARVs), used in the treatment of Aids.
It had filed a patent application on the new technology, the CSIR said in a statement on Monday.
"In South Africa, with the number of people requiring ARV drugs estimated at approaching one million... the local manufacturing of these drugs is an imperative," CSIR biosciences research unit director Gatsha Mazithulela said.
The challenge now was to find commercial partners willing to invest in manufacturing.
"We look forward to interesting conversations with our government and other stakeholders in making local production of ARVs a reality," he said.
EMAIL THIS ARTICLE SAVE THIS ARTICLE FEEDBACK
To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here
